Quick Answer
MACROGENICS INC reported Earnings Per Share Diluted of $1.18 (loss) per share for the year ending 2025.
- MACROGENICS INC showed a decrease of -10.3% in Earnings Per Share Diluted from 2024 to 2025.
- This data is from MACROGENICS INC's annual report (Form 10-K), filed with the SEC on March 9, 2026.
- XBRL data for this metric is available from 2011 to 2025 (9 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2012: $0.00 per share | Q2 2012: $0.00 per share | Q3 2012: $0.00 per share | Q4 2012: $1.92 (loss) per share | Q1 2013: $2.93 (loss) per share | Q2 2013: $0.24 (loss) per share | Q3 2013: $0.01 per share | Q4 2013: $0.14 (loss) per share | Q1 2014: $0.12 (loss) per share | Q2 2014: $0.44 (loss) per share | Q3 2014: $0.14 (loss) per share | Q1 2015: $1.42 per share | Q2 2015: $0.71 (loss) per share | Q3 2015: $0.46 (loss) per share | Q1 2016: $0.88 (loss) per share | Q2 2016: $1.12 per share | Q3 2016: $0.97 (loss) per share | Q2 2017: $1.14 (loss) per share | Q2 2020: $0.94 (loss) per share | Q3 2020: $0.66 (loss) per share | Q1 2021: $0.90 (loss) per share | Q2 2021: $0.66 (loss) per share | Q3 2021: $0.86 (loss) per share | Q1 2022: $1.08 (loss) per share | Q2 2022: $0.67 (loss) per share | Q3 2022: $0.40 (loss) per share | Q1 2023: $0.61 (loss) per share | Q2 2023: $0.92 per share | Q3 2023: $0.28 per share | Q1 2024: $0.84 (loss) per share | Q2 2024: $0.89 (loss) per share | Q3 2024: $0.90 per share | Q1 2025: $0.65 (loss) per share | Q2 2025: $0.57 (loss) per share | Q3 2025: $0.27 per share.
- Historical annual values: Fiscal year 2025: $1.18 (loss) per share | Fiscal year 2024: $1.07 (loss) per share | Fiscal year 2023: $0.15 (loss) per share | Fiscal year 2022: $1.95 (loss) per share | Fiscal year 2021: $3.37 (loss) per share | Fiscal year 2020: $2.47 (loss) per share | Fiscal year 2013: $0.04 (loss) per share | Fiscal year 2012: $0.00 per share | Fiscal year 2011: $0.00 per share.
- Data sourced from SEC EDGAR public filings as of August 9, 2026.
Last verified: